Dr Shubha Anand and Dr Ezequiel Martin-Rodriguez discuss the Cancer Molecular Diagnostics Laboratory (CMDL) at the CRUK Cambridge Centre, UK and how it enables clinical trials and translational studies. CMDL was established in 2015 to develop new technologies in relation to detailed molecular genetic profiling using next generation sequencing and for sequencing modified bases in DNA. They collect samples for molecular analysis and extractions as well as helping to set up new assays, providing a bespoke service for all Integrated Cancer Medicine Programme trials and studies and beyond.

Shubha is the Director of the Cancer Molecular Diagnostics Laboratory at the University of Cambridge, UK.

Ezequiel is Senior Bioinformatician within the Cancer Molecular Diagnostics Laboratory at the University of Cambridge, UK.